Synapse

← Journal of Clinical Pharmacy and Therapeutics

Papers in Journal of Clinical Pharmacy and Therapeutics

Page 4 · newest first

  1. Dihydromyricetin Alleviates Nonalcoholic Fatty Liver Disease and Its Associated Metabolic Syndrome by Inhibiting Endoplasmic Reticulum Stress in LDLR−/− Mice Fed with a High‐Fat and High‐Fructose DietJournal of Clinical Pharmacy and Therapeutics · 2023
  2. Evaluation of Vancomycin Utilization in the Medical and Gynecology Wards of Felege Hiwot Comprehensive Specialized Hospital, Northwest EthiopiaJournal of Clinical Pharmacy and Therapeutics · 2023
  3. Poor Correlation of Rivaroxaban Concentration with the Routine Coagulation Screening Test in Chinese Patients with Atrial FibrillationJournal of Clinical Pharmacy and Therapeutics · 2023
  4. Exploration of the Mechanism of Valsartan Treatment in Chronic Renal Failure: Network Pharmacology and Experimental ValidationJournal of Clinical Pharmacy and Therapeutics · 2023
  5. Efficacy and Safety of Hetrombopag for Thrombocytopenia in Patients with Advanced Solid Tumors: A Retrospective StudyJournal of Clinical Pharmacy and Therapeutics · 2023
  6. Development and Internal Validation of Machine Learning Algorithms for Determining Sodium Valproate Concentrations below the Standard Level Using a Risk Prediction Model of Children with EpilepsyJournal of Clinical Pharmacy and Therapeutics · 2023
  7. Median Effective Dose of an Etomidate‐Propofol Mixture with Dezocine in Inhibiting the Response to Gastroscope Insertion: Gender Differences in a Randomized Controlled Study Using Dixon’s Up‐and‐Down MethodJournal of Clinical Pharmacy and Therapeutics · 2023
  8. Effect of Integrated Treatment with Traditional Chinese Medicine on Hashimoto’s Thyroiditis PatientsJournal of Clinical Pharmacy and Therapeutics · 2023
  9. A Systematic Review and Meta‐Analysis: Safety and Efficacy of Cediranib in the Treatment of Cancer PatientsJournal of Clinical Pharmacy and Therapeutics · 2023
  10. Digestive Tract Cancer‐Related Adverse Events Correlated with Proton Pump Inhibitors Use: A Pharmacovigilance Study of the FDA Adverse Event Reporting SystemJournal of Clinical Pharmacy and Therapeutics · 2023
  11. Factors Influencing Blood Concentration of Voriconazole and Therapeutic Drug Monitoring in Patients with Child–Pugh Class C CirrhosisJournal of Clinical Pharmacy and Therapeutics · 2023
  12. Antimicrobial Resistance and Biofilm Production in Uropathogens from Renal Disease Patients Admitted to Tribhuvan University Teaching Hospital, NepalJournal of Clinical Pharmacy and Therapeutics · 2023
  13. Efficacy and Safety of Integrated Maxing Shigan Decoction and Azithromycin for Mycoplasma Pneumoniae Pneumonia in Children: A Systematic Review and Meta‐AnalysisJournal of Clinical Pharmacy and Therapeutics · 2023
  14. Clinical Effectiveness and Outcomes of Azithromycin versus Doxycycline Containing Regimen in Inpatients with Community Acquired Pneumonia: A Retrospective Cohort StudyJournal of Clinical Pharmacy and Therapeutics · 2023
  15. Preparation and Evaluation of Onjisaponin B‐Loaded Liposomes for Drug Delivery to Enhance Mitochondrial Function and Rescue Parkinson’s Disease by Activating MitophagyJournal of Clinical Pharmacy and Therapeutics · 2023
  16. Challenges and Proven Recommendations of Praziquantel FormulationJournal of Clinical Pharmacy and Therapeutics · 2023
  17. Six months multicentre pilot open label single‐arm study to evaluate patient experience, acceptability and satisfaction of switching certolizumab pegol from a prefilled syringe or autoinjection pen to an AVA ® e‐Device in rheumatoid arthritis, psoriatic arthritis and axial spondyloarthritis patientsJournal of Clinical Pharmacy and Therapeutics · 2022
  18. Pharmacokinetic/pharmacodynamic analysis of high‐dose tigecycline, by Monte Carlo simulation, in plasma and sputum of patients with hospital‐acquired pneumoniaJournal of Clinical Pharmacy and Therapeutics · 2022
  19. VANCOmycin dose adjustments comparing trough levels to the ratio of the area under de curve to the minimum inhibitory concentration method using a BAYESian approach: A feasibility studyJournal of Clinical Pharmacy and Therapeutics · 2022
  20. Tumour necrosis factor inhibitor combined with intravenous immunoglobulin and heparin for treatment of recurrent spontaneous abortion: A two‐centre, retrospective, cohort studyJournal of Clinical Pharmacy and Therapeutics · 2022
  21. The efficacy and safety of intravenous tirofiban in the treatment of acute ischemic stroke patients with early neurological deteriorationJournal of Clinical Pharmacy and Therapeutics · 2022
  22. Progress of triazole antifungal agent posaconazole in individualized therapyJournal of Clinical Pharmacy and Therapeutics · 2022
  23. Impact of mulberry consumption on cardiometabolic risk factors: A systematic review and meta‐analysis of randomized‐controlled trialsJournal of Clinical Pharmacy and Therapeutics · 2022
  24. Severe lung injury induced by CD38 monoclonal antibody Daratumumab and bortezomib‐containing regimen in a patient with preexisting interstitial lung disease: a case report and literature reviewJournal of Clinical Pharmacy and Therapeutics · 2022
  25. A randomized, double‐blind placebo‐controlled phase I clinical study on safety and efficacy of the G‐Rup ® syrup (a mixture of ginger extract and honey) in symptomatic treatment of knee osteoarthritisJournal of Clinical Pharmacy and Therapeutics · 2022
  26. Management of biologics in pregnant, lactating patients with inflammatory bowel disease and the impact on neonatal vaccination: A systematic review of clinical practice guidelines and consensus statementsJournal of Clinical Pharmacy and Therapeutics · 2022
  27. Concomitant administration of warfarin and toremifene: A case reportJournal of Clinical Pharmacy and Therapeutics · 2022
  28. The efficacy of oral corticosteroids for treatment of Tietze syndrome: A pragmatic randomized controlled trialJournal of Clinical Pharmacy and Therapeutics · 2022
  29. Effectiveness and safety of path‐based analgesic regimens designed by clinical pharmacists based on the type of biliary and pancreatic surgeryJournal of Clinical Pharmacy and Therapeutics · 2022
  30. Real‐world use of IBI305 , a bevacizumab biosimilar, in a tertiary caner‐specialized hospital in ChinaJournal of Clinical Pharmacy and Therapeutics · 2022
  31. Asparaginase‐related diabetic ketoacidosis: Analysis of the FDA Adverse Event Reporting System ( FAERS ) data and literature reviewJournal of Clinical Pharmacy and Therapeutics · 2022
  32. Effects of the international economic sanctions on access to medicine of the Iranian people: A systematic reviewJournal of Clinical Pharmacy and Therapeutics · 2022
  33. Test performance of self‐report adherence tools in patients with hypertension: A systematic review and a meta‐analysisJournal of Clinical Pharmacy and Therapeutics · 2022
  34. The role of the clinical pharmacist in the prevention of drug‐induced acute kidney injury in the intensive care unitJournal of Clinical Pharmacy and Therapeutics · 2022
  35. Influence of CYP3A4 *22 and CYP3A5 *3 combined genotypes on tacrolimus dose requirements in Egyptian renal transplant patientsJournal of Clinical Pharmacy and Therapeutics · 2022
  36. Central nervous system adverse events of ceftazidime/avibactam: A retrospective study using Food and Drug Administration Adverse Event Reporting SystemJournal of Clinical Pharmacy and Therapeutics · 2022
  37. Dosage optimization of voriconazole in children with haematological malignancies based on population pharmacokineticsJournal of Clinical Pharmacy and Therapeutics · 2022
  38. Efficacy and safety of rituximab biosimilars or reference product as first‐line treatment in patients with low‐tumour‐burden follicular lymphoma: A systematic review and meta‐analysisJournal of Clinical Pharmacy and Therapeutics · 2022
  39. Remimazolam versus propofol for deep sedation/anaesthesia in upper gastrointestinal endoscopy in elderly patients: A multicenter, randomized controlled trialJournal of Clinical Pharmacy and Therapeutics · 2022
  40. The correlation between paclitaxel chemotoxicity and the plasma albumin level in cancer patientsJournal of Clinical Pharmacy and Therapeutics · 2022
  41. The effect of changing to Bictegravir on lipids using real world data: A brief reportJournal of Clinical Pharmacy and Therapeutics · 2022
  42. Diagnostic value of bronchoalveolar lavage fluid galactomannan assay for invasive pulmonary aspergillosis in adults: A meta‐analysisJournal of Clinical Pharmacy and Therapeutics · 2022
  43. Evaluation of the Tocilizumab therapy in human cancers: Latest evidence and clinical potentialJournal of Clinical Pharmacy and Therapeutics · 2022
  44. Risk factors for high‐dose methotrexate associated toxicities in patients with primary central nervous system lymphomaJournal of Clinical Pharmacy and Therapeutics · 2022
  45. Prevalence and risk factors associated with readmission with acute kidney injury in patients receiving vancomycin outpatient parenteral antimicrobial therapyJournal of Clinical Pharmacy and Therapeutics · 2022
  46. Management ofdrug‐inducedneutropenia, thrombocytopenia, and anaemia after solid organ transplantation: A comprehensive reviewJournal of Clinical Pharmacy and Therapeutics · 2022
  47. Heparin‐induced persistent hyperthermia with recurrent hyponatremia in hip fracture: Case report and review of literatureJournal of Clinical Pharmacy and Therapeutics · 2022
  48. The Inflation Reduction Act: A boon for the generic and biosimilar industryJournal of Clinical Pharmacy and Therapeutics · 2022
  49. Acinetobacter baumannii : Pathogenesis, virulence factors, novel therapeutic options and mechanisms of resistance to antimicrobial agents with emphasis on tigecyclineJournal of Clinical Pharmacy and Therapeutics · 2022
  50. Safety of trastuzumab deruxtecan: A meta‐analysis and pharmacovigilance studyJournal of Clinical Pharmacy and Therapeutics · 2022